GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (BUE:TMO) » Definitions » Other Net Income (Loss)

Thermo Fisher Scientific (BUE:TMO) Other Net Income (Loss) : ARS10,070 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Thermo Fisher Scientific Other Net Income (Loss)?

Thermo Fisher Scientific's Other Net Income (Loss) for the three months ended in Mar. 2024 was ARS20,220 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ARS10,070 Mil.

Thermo Fisher Scientific's quarterly Other Net Income (Loss) increased from Sep. 2023 (ARS-5,949 Mil) to Dec. 2023 (ARS-361 Mil) and increased from Dec. 2023 (ARS-361 Mil) to Mar. 2024 (ARS20,220 Mil).

Thermo Fisher Scientific's annual Other Net Income (Loss) declined from Dec. 2021 (ARS-404 Mil) to Dec. 2022 (ARS-28,836 Mil) but then increased from Dec. 2022 (ARS-28,836 Mil) to Dec. 2023 (ARS-21,299 Mil).


Thermo Fisher Scientific Other Net Income (Loss) Historical Data

The historical data trend for Thermo Fisher Scientific's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thermo Fisher Scientific Other Net Income (Loss) Chart

Thermo Fisher Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -244.14 -403.96 -28,835.80 -21,299.00

Thermo Fisher Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,938.75 -3,840.00 -5,949.15 -361.00 20,220.00

Thermo Fisher Scientific Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS10,070 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thermo Fisher Scientific Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Thermo Fisher Scientific (BUE:TMO) Business Description

Address
168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).